Lopinavir - Ritonavir No Benefit in Patients Admitted With COVID - 19
No reductions seen in 28 - day mortality or duration of hospital stay in COVID - 19 with lopinavir - ritonavir
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Infections, Nursing, Pharmacy, Pulmonology, Critical Care, Emergency Medicine, Journal, Source Type: news
More News: COVID-19 | Emergency Medicine | Hospitals | Kaletra | Norvir | Nurses | Nursing | Respiratory Medicine